{
    "ticker": "OSUR",
    "name": "Orasure Technologies, Inc.",
    "description": "Orasure Technologies, Inc. is a leading provider of oral fluid diagnostic tests and devices, specializing in innovative solutions for the healthcare industry. Founded in 1990 and headquartered in Bethlehem, Pennsylvania, the company focuses on developing, manufacturing, and marketing a range of diagnostic products that enable rapid and accurate testing for various medical conditions. Orasure is particularly well-known for its oral fluid testing technologies, which provide a non-invasive alternative to traditional blood tests for the detection of infectious diseases, including HIV and hepatitis. Their flagship products, including the OraQuick\u00ae test, have been instrumental in increasing access to testing and facilitating early diagnosis. In addition to infectious disease testing, Orasure also develops and markets products for drug testing and other medical applications. The company is dedicated to improving public health and has established partnerships with various organizations to expand the reach and impact of its testing solutions. With a strong emphasis on research and development, Orasure is committed to advancing diagnostic technologies and enhancing patient care globally.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "Bethlehem, Pennsylvania, USA",
    "founded": "1990",
    "website": "https://www.orasure.com",
    "ceo": "Stephen S. Tang",
    "social_media": {
        "twitter": "https://twitter.com/Orasure",
        "linkedin": "https://www.linkedin.com/company/orasure-technologies/"
    },
    "investor_relations": "https://investor.orasure.com",
    "key_executives": [
        {
            "name": "Stephen S. Tang",
            "position": "CEO"
        },
        {
            "name": "Gail K. D. K. Z. A. G. M. A. H. S.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Infectious Disease Testing",
            "products": [
                "OraQuick\u00ae HIV Test",
                "OraQuick\u00ae HCV Test"
            ]
        },
        {
            "category": "Drug Testing",
            "products": [
                "Interlaced\u00ae Oral Fluid Drug Testing Devices"
            ]
        }
    ],
    "seo": {
        "meta_title": "Orasure Technologies, Inc. | Innovative Oral Fluid Diagnostic Solutions",
        "meta_description": "Explore Orasure Technologies, Inc., a leader in oral fluid diagnostic tests and devices. Discover their innovative solutions for infectious disease and drug testing.",
        "keywords": [
            "Orasure",
            "Oral Fluid Testing",
            "HIV Testing",
            "HCV Testing",
            "Drug Testing",
            "Medical Devices"
        ]
    },
    "faq": [
        {
            "question": "What is Orasure Technologies known for?",
            "answer": "Orasure Technologies is known for its innovative oral fluid diagnostic tests and devices, particularly for infectious diseases and drug testing."
        },
        {
            "question": "Who is the CEO of Orasure Technologies?",
            "answer": "Stephen S. Tang is the CEO of Orasure Technologies, Inc."
        },
        {
            "question": "Where is Orasure headquartered?",
            "answer": "Orasure is headquartered in Bethlehem, Pennsylvania, USA."
        },
        {
            "question": "What are Orasure's main products?",
            "answer": "Orasure's main products include the OraQuick\u00ae HIV Test and oral fluid drug testing devices."
        },
        {
            "question": "When was Orasure founded?",
            "answer": "Orasure was founded in 1990."
        }
    ],
    "competitors": [
        "LH",
        "RMD",
        "DGX"
    ],
    "related_stocks": [
        "ABT",
        "PFE",
        "BDX",
        "MDT"
    ]
}